These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24625334)

  • 1. The velocity of home blood pressure reduction in response to low-dose eplerenone combined with other antihypertensive drugs determined by exponential decay function analysis.
    Elnagar N; Satoh M; Hosaka M; Asayama K; Ishikura K; Obara T; Mano N; Ohkubo T; Imai Y
    Clin Exp Hypertens; 2014; 36(2):83-91. PubMed ID: 24625334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.
    Karagiannis A; Tziomalos K; Papageorgiou A; Kakafika AI; Pagourelias ED; Anagnostis P; Athyros VG; Mikhailidis DP
    Expert Opin Pharmacother; 2008 Mar; 9(4):509-15. PubMed ID: 18312153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home.
    Hashimoto J; Hirayama H; Hanasawa T; Watabe D; Asayama K; Metoki H; Kikuya M; Ohkubo T; Totsune K; Imai Y
    Clin Exp Hypertens; 2005 May; 27(4):331-41. PubMed ID: 15921070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can renin status predict the antihypertensive efficacy of eplerenone add-on therapy?
    Prisant LM; Krum H; Roniker B; Krause SL; Fakouhi K; He W
    J Clin Pharmacol; 2003 Nov; 43(11):1203-10. PubMed ID: 14551174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Masked Hypertension in Subjects Treated with Antihypertensive Drugs as Assessed by Morning versus Evening Home Blood Pressure Measurements: the J-HOME study.
    Obara T; Ohkubo T; Asayama K; Kikuya M; Metoki H; Inoue R; Komai R; Murai K; Hashimoto J; Totsune K; Imai Y;
    Clin Exp Hypertens; 2008 Apr; 30(3):277-87. PubMed ID: 18425707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension.
    White WB; Carr AA; Krause S; Jordan R; Roniker B; Oigman W
    Am J Cardiol; 2003 Jul; 92(1):38-42. PubMed ID: 12842242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of eplerenone added to renin-angiotensin blockade in elderly hypertensive patients: the Jichi-Eplerenone Treatment (JET) study.
    Yano Y; Hoshide S; Tamaki N; Nagata M; Sasaki K; Kanemaru Y; Shimada K; Kario K
    J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):340-7. PubMed ID: 21393354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension.
    Williams GH; Burgess E; Kolloch RE; Ruilope LM; Niegowska J; Kipnes MS; Roniker B; Patrick JL; Krause SL
    Am J Cardiol; 2004 Apr; 93(8):990-6. PubMed ID: 15081441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Analysis of The Effectiveness of Antihypertensive Therapy Including Spironolactone and Eplerenone in Patients With Essential Hypertension and Atrial Fibrillation.
    Abdullaeva GZ; Radzhabova GM; Sherbadalova NH; Pulatova MT; Mashkurova ZT; Alieva RB; Khatamova MN; Ibragimov NN
    Kardiologiia; 2024 Sep; 64(9):70-79. PubMed ID: 39392269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats.
    Nakamura T; Fukuda M; Kataoka K; Nako H; Tokutomi Y; Dong YF; Yamamoto E; Yasuda O; Ogawa H; Kim-Mitsuyama S
    Hypertens Res; 2011 Jul; 34(7):817-24. PubMed ID: 21471977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eplerenone, an aldosterone blocker, is more effective in reducing blood pressure in patients with, than without, metabolic syndrome.
    Suzuki H; Shuto H; Shuto C; Ohara I; Inokuma S; Abe Y; Sukigara M
    Ther Adv Cardiovasc Dis; 2012 Aug; 6(4):141-7. PubMed ID: 22751654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The velocity of antihypertensive effect of losartan/hydrochlorothiazide and angiotensin II receptor blocker.
    Metoki H; Ohkubo T; Kikuya M; Asayama K; Inoue R; Obara T; Hirose T; Sato M; Hashimoto T; Imai Y;
    J Hypertens; 2012 Jul; 30(7):1478-86. PubMed ID: 22573119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.
    Epstein M; Williams GH; Weinberger M; Lewin A; Krause S; Mukherjee R; Patni R; Beckerman B
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):940-51. PubMed ID: 17699311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.
    Nishimura T; Hashimoto J; Ohkubo T; Kikuya M; Metoki H; Asayama K; Totsune K; Imai Y
    Clin Exp Hypertens; 2005 Aug; 27(6):477-89. PubMed ID: 16081340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension.
    Burgess ED; Lacourcière Y; Ruilope-Urioste LM; Oparil S; Kleiman JH; Krause S; Roniker B; Maurath C
    Clin Ther; 2003 Sep; 25(9):2388-404. PubMed ID: 14604739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a selective aldosterone blocker and thiazide-type diuretic on blood pressure and organ damage in hypertensive patients.
    Ohta Y; Ishizuka A; Hayashi S; Iwashima Y; Kishida M; Yoshihara F; Nakamura S; Kawano Y
    Clin Exp Hypertens; 2015; 37(7):569-73. PubMed ID: 25992488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?
    Verdalles U; García de Vinuesa S; Goicoechea M; Macías N; Santos A; Perez de Jose A; Verde E; Yuste C; Luño J
    Nephrology (Carlton); 2015 Aug; 20(8):567-71. PubMed ID: 25818266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
    Moore TD; Nawarskas JJ; Anderson JR
    Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which measurement of home blood pressure should be used for clinical evaluation when multiple measurements are made?
    Kawabe H; Saito I
    J Hypertens; 2007 Jul; 25(7):1369-74. PubMed ID: 17563557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.